DRUG
Bright Minds Biosciences Inc
NASDAQ: DRUG · HEALTHCARE · BIOTECHNOLOGY
$89.11
+0.13% today
Updated 2026-04-29
Market cap
$872.62M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.02
Dividend yield
—
52W range
$23 – $124
Volume
0.2M
Bright Minds Biosciences Inc (DRUG) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |